A recent study including proteomics of potential insulin resistance biomarkers in PCOS women showed that only ApoC3 was flagged as potentially being a diagnostic marker for PCOS-insulin-resistant subjects [39]; however, in this study, ApoC3 was not available in the Somascan panel. This evidence concerns the gene APOC3 and polycystic ovary syndrome.